PL4009942T3 - Związek służący do leczenia skojarzonego - Google Patents

Związek służący do leczenia skojarzonego

Info

Publication number
PL4009942T3
PL4009942T3 PL20751149.4T PL20751149T PL4009942T3 PL 4009942 T3 PL4009942 T3 PL 4009942T3 PL 20751149 T PL20751149 T PL 20751149T PL 4009942 T3 PL4009942 T3 PL 4009942T3
Authority
PL
Poland
Prior art keywords
compound
combination treatment
treatment
combination
Prior art date
Application number
PL20751149.4T
Other languages
English (en)
Inventor
Ulf Simonsen
Simon COMERMA-STEFFENSEN
Dan Peters
Original Assignee
Initiator Pharma A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Initiator Pharma A/S filed Critical Initiator Pharma A/S
Publication of PL4009942T3 publication Critical patent/PL4009942T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PL20751149.4T 2019-08-06 2020-08-06 Związek służący do leczenia skojarzonego PL4009942T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19190224 2019-08-06
PCT/EP2020/072092 WO2021023805A1 (en) 2019-08-06 2020-08-06 Compound for combination treatment

Publications (1)

Publication Number Publication Date
PL4009942T3 true PL4009942T3 (pl) 2024-04-08

Family

ID=67551141

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20751149.4T PL4009942T3 (pl) 2019-08-06 2020-08-06 Związek służący do leczenia skojarzonego

Country Status (16)

Country Link
US (1) US20220288052A1 (pl)
EP (2) EP4241839A3 (pl)
JP (1) JP7605825B2 (pl)
KR (1) KR20220054593A (pl)
CN (1) CN114430679A (pl)
AU (1) AU2020326244B2 (pl)
BR (1) BR112022002169A2 (pl)
CA (1) CA3146837A1 (pl)
DK (1) DK4009942T3 (pl)
ES (1) ES2962648T3 (pl)
FI (1) FI4009942T3 (pl)
IL (1) IL290319B2 (pl)
MX (1) MX2022000356A (pl)
PL (1) PL4009942T3 (pl)
WO (1) WO2021023805A1 (pl)
ZA (1) ZA202200723B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120813353A (zh) * 2023-01-03 2025-10-17 创始人制药股份有限公司 用于治疗勃起功能障碍的化合物
WO2025051846A1 (en) 2023-09-05 2025-03-13 Initiator Pharma A/S Compound for treatment of female sexual dysfunction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050288355A1 (en) * 2002-06-20 2005-12-29 Arne Mork Combination therapy wherein a serotonin reuptake inhibitor is used
JP2009513539A (ja) * 2003-07-11 2009-04-02 ベーリンガー・インゲルハイム・フエトメデイカ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング ベンゾジアゼピンレセプターのアルファ３サブユニットに対する選択性を有する化合物を用いて中枢神経系障害を治療または予防する方法
EP1797088B1 (en) * 2004-09-30 2011-01-05 NeuroSearch A/S Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20090312364A1 (en) * 2006-12-20 2009-12-17 Neurosearch A/S Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
BRPI0917802A2 (pt) * 2008-08-21 2016-03-01 Neurosearch As método para tratar um distúrbio de ansiedade, composição farmacêutica, uso do composto, uso de uma combinação, kit de partes, método para tratar, prevenir ou aliviar um distúrbio de ansiedade de um corpo de animal vivo, e, combinação
WO2011092061A1 (en) * 2010-01-29 2011-08-04 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Also Published As

Publication number Publication date
DK4009942T3 (da) 2023-10-23
EP4009942A1 (en) 2022-06-15
JP2022544463A (ja) 2022-10-19
IL290319A (en) 2022-04-01
AU2020326244B2 (en) 2025-06-05
KR20220054593A (ko) 2022-05-03
AU2020326244A1 (en) 2022-03-17
MX2022000356A (es) 2022-05-11
CA3146837A1 (en) 2021-02-11
ZA202200723B (en) 2022-08-31
CN114430679A (zh) 2022-05-03
FI4009942T3 (fi) 2023-09-26
IL290319B2 (en) 2023-06-01
ES2962648T3 (es) 2024-03-20
EP4241839A2 (en) 2023-09-13
EP4009942B1 (en) 2023-08-09
EP4241839A3 (en) 2023-11-15
US20220288052A1 (en) 2022-09-15
JP7605825B2 (ja) 2024-12-24
BR112022002169A2 (pt) 2022-06-07
WO2021023805A1 (en) 2021-02-11

Similar Documents

Publication Publication Date Title
IL292753A (en) Compounds
IL283692A (en) Novel composition
IL285771A (en) Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
DK4083038T3 (da) Pyridazinylthiazolcarboxamidforbindelse
IL286833A (en) Compositions containing brazzein
LT3810602T (lt) Junginiai
HUE057323T2 (hu) Hemoglobin módosítására alkalmas 2-formil-3-hidroxi-feniloximetil-vegyületek
IL290561A (en) Alkynyl quinazoline compounds
IL282330A (en) Therapeutic compounds
EP3742771C0 (en) M2M SM-SR TO SM-DP NOTIFICATION
HUE065134T2 (hu) Vegyületek
LT4034122T (lt) Hiperfenilalaninemijos gydymo būdai
IL281845A (en) Combination therapy for the treatment of cancer
DK3808747T3 (da) Imidazopyridinon-forbindelse
LT3867247T (lt) Naujieji junginiai
IL280968A (en) Combination therapy
EP4025203A4 (en) CANCER TREATMENT
EP3902806C0 (en) THIENOPYRIDINONE COMPOUNDS
DK3908733T3 (da) Brøndfremgangsmåde
DK3738452T3 (da) Fordamper
EP3856207A4 (en) TREATMENT PROCESSES
IL288237A (en) Combination therapy
IL290319A (en) Compound for combined treatment
IL290261A (en) Treatment of canine cancers
EP3986109C0 (en) PLASMA TREATMENT